The leader in quality education and networking through//conferences, courses and custom training
Connect with IBC Life Sciences:LinkedIn iconTwitter iconFacebook iconRSS icon
EmailPrint

Diagnostics

  • TIDES: Oligonucleotide and Peptide Therapeutics from Research through Commercialization
    May 12-15, 2014
    Rhode Island Convention Center, Providence, RI
    Join 750 global oligonucleotide and peptide professionals at TIDES 2014, where you will access the latest science, technologies and regulations needed to advance your product from discovery to clinic to market. Our 2014 program includes tons of exciting new updates, speakers and topics to keep you on the pulse of this evolving industry. Whether your focus is on oligonucleotides or peptides, discovery or manufacturing, TIDES 2014 is the one-stop conference to advance your research, development and process chemistry efforts forward.
  • Personalized Medicine Technology and Analytics Forum
    September 19, 2014
    Philadelphia, PA, United States
    IBC Life Sciences present a new event, Personalized Medicine Technology and Analytics Forum: Bridging Diagnostics and Data for Drug Discovery and Laboratory Professionals. Learn about the latest developments in technology for precision medicine and related companion diagnostics, find out how effective data analytics can speed up personalized medicine growth and dive into issues surrounding clinical trials for stratified health care products.
  • Antibody Engineering & Therapeutics
    December 07-11, 2014
    Hyatt Regency Huntington Beach Resort & Spa, Huntington Beach, CA
    IBC's Antibody Engineering & Therapeutics conference is an invaluable resource for your research programs. Attending these meetings means getting important updates from the early stage work of leading academic researchers and tracking the progress of companies advancing antibody therapeutics through clinical development. Covering both cutting-edge developments in the basic science of antibody engineering and clinical/preclinical updates of therapeutic antibodies in development.